Magenta Therapeutics Launches Proposed Public Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 29, 2019--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative…
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 29, 2019--Magenta Therapeutics, Inc. (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative…